George B. Stefano, Richard M. Kream influence human health. REVIEW. Neuro Endocrinol Lett 2010; 31: 9. 48. Mantione KJ, Sheehan M, Gerber S, et al. Microarray validation of vertebrate biogenic amine and acetylcholine signaling in invertebrates. Biogenic Amines 2010; in press. 49. Mantione KJ, Zhu W, Kream RM, Esch T, Stefano GB. Regulation of the transcription of the catechol-O- methyltransferase gene by morphine and epinephrine. Activitas Nervosa Superior Rediviva 2010; in press. 50. Cadet P, Mantione KJ, Zhu W, Kream RM, Sheehan M, Stefano GB. A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi- lineage progenitor cells. J Immunol 2007; 179: 5839-44. 51. Dobrenis K, Makman MH, Stefano GB. Occurrence of the opiate alkaloid-selective m3 receptor in mammalian microglia, astrocytes and kupffer cells. Brain Res 1995; 686: 239-48. 52. Makman MH, Bilfinger TV, Stefano GB. Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol 1995; 154: 1323-30. 53. Makman MH, Dvorkin B, Stefano GB. Murine macrophage cell lines contain m3-opiate receptors. Eur J Pharmacol 1995; 273: R5-6. 54. Kream RM, Sheehan M, Cadet P, et al. Persistence of evolutionary memory: primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit 2007; 13: SC5-6. 55. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science 1992; 258: 1952-5. 56. Kieffer BL, Befort K, Gaveriaux-Ruff CE, Hirth CG. The d- opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 1992; 89: 12048-52. 57. Yasuda K, Raynor K, Kong H, et al. Cloning and functional comparison of k and d-opioid receptors from mouse brain. Proc Natl Acad Sci USA 1993; 90: 6736-40. 58. Hakusui S, Yasuda T, Yanagi T, et al. A radiological analysis of heart sympathetic functions with meta-[123I]iodo- benzylguanidine in neurological patients with autonomic failure. J Aut Nerv Sys 1994; 49: 81-4. 59. Jankovic BD, Radulovic J. Quaternary naltrexone: its immunomodulatory activity and interaction with brain delat and kappa opioid receptors. Immunopharmacology 1994; 28: 105-12. 60. Duvaux-Miret O, Stefano GB, Smith EM, Dissous C, Cap- ron A. Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides. Proc Natl Acad Sci USA 1992; 89: 778-81. 61. Duvaux-Miret O, Stefano GB, Smith EM, Mallozzi L, Cap- ron A. Proopiomelanocortin-derived peptides as tools of immune evasion for the human trematode Schistosoma mansoni. Acta Biol Hungari 1992; 43: 281-6. 62. Duvaux-Miret O, Stefano GB, Smith EM, Capron A. Neuroimmunology of host parasite interactions: pro- opiomelanocortin derivedpeptides in the infection by Schistosoma mansoni. Adv Neuroimmunol 1992; 2: 297-311. 63. Duvaux-Miret O, Capron A. Proopiomelanocortin in the helminth Schistosoma mansoni. Synthesis of b- endorphin, ACTH and a-MSH. Existence of POMC-related sequences. Ann N Y Acad Sci 1992; 650: 245-50. 64. Poole S, Bristow AF, Lorenzetti BB, Das RE, Smith TW, Ferreira SH. Peripheral analgesic activities of peptides related to alpha- melanocyte stimulating hormone and inter- leukin-1 beta 193-195. Br J Pharmacol 1992; 106: 489-92. 65. Smith EM, Hughes TK, Hashemi F, Stefano GB. Immuno- suppressive effects of ACTH and MSH and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1992; 89: 782-6. 66. Smith EM, Hughes TK, Cadet P, Stefano GB. CRF induced immunosuppression in human and invertebrate immunocytes. Cell Mol Neurobiol 1992; 12: 473-82. 67. Kream RM, Stefano GB. De novo biosynthesis of morphine in animal cells: an evidence-based model. Med Sci Monit 2006; 12: RA207-19. 68. Zhu W, Cadet P, Mantione KJ, Kream RM, Stefano GB. Response to comment on "Human white blood cells synthesize morphine: CYP2D6 modulation". J Immunol 2006; 176: 5704. 69. Castardeli E, Duarte DR, Minicucci MF, et al. Exposure time and ventricular remodeling induced by tobacco smoke exposure in rats. Med Sci Monit 2008; 14: BR62-6. 70. Tanii H, Higashi T, Nishimura F, Higuchi Y, Saijoh K. Effects of cruciferous allyl nitrile on phase 2 antioxidant and detoxification enzymes. Med Sci Monit 2008; 14: BR189-92. 71. Zhu W. CYP2D6: a key enzyme in morphine synthesis in animals. Med Sci Monit 2008; 14: SC15-8. 72. Gu Y, Yun L, Tian Y, Hu Z. Association between COMT gene and Chinese male schizophrenic patients with violent behavior. Med Sci Monit 2009; 15: CR484-9. 73. Naha N, Lee HY, Naser MI, Park TJ, Kim SH, Kim MO. Ethanol inhibited apoptosis-related RNA binding protein, Napor-3 gene expression in the prenatal rat brain. Med Sci Monit 2009; 15: BR6-12. 74. Zhu W, Mantione KJ, Casares FM, et al. Alcohol-, nicotine, and cocaine-evoked release of morphine from invertebrate ganglia: Model system for screening drugs of abuse. Med Sci Monit 2006; 12: BR155-61. 75. Zhu W, Mantione KJ, Shen L, Lee B, Stefano GB. Norlaudanosoline and nicotine increase endogenous ganglionic morphine levels: Nicotine addiction. Cell Mol Neurobiol 2006; 26: 1037-45. 76. Zhu W, Mantione K, Kream RM, Stefano GB. Alcohol-, nicotine-, and cocaine-evoked release of morphine from human white blood cells: substances of abuse actions converge on endogenous morphine release. Med Sci Monit 2006; 12: BR350-4. 460 Arch Med Sci 3, June / 2010